Ufenamate

Ufenamate

SCHEMBL36095

CCCCOC(=O)c1ccccc1Nc1cccc(C(F)(F)F)c1

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.72
CYP2C19 P33261 2/20 0.72
LMNA P02545 1/20 0.72
CYP2C9 P11712 1/20 0.72
YAP1 P46937 1/20 0.60
TEAD4 Q15561 1/20 0.60
TEAD2 Q15562 1/20 0.60
RXFP1 Q9HBX9 8/20 0.59
TSHR P16473 2/20 0.52
TDP1 Q9NUW8 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
AKR1C3 P42330 2/20 0.51
AKR1C2 P52895 2/20 0.51
SIRT2 Q8IXJ6 1/20 0.51
MPO P05164 3/20 0.49
SMN1; SMN2 Q16637 1/20 0.48
TP53 P04637 1/20 0.48
CYP3A4 P08684 1/20 0.48
MAPK1 P28482 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ufenamate SCHEMBL29376700 1.00 CYP1A2 (0.72) CYP1A2CYP2C19LMNACYP2C9YAP1
SCHEMBL10597386 0.89 LMNA (0.71) CYP1A2CYP2C19LMNACYP2C9YAP1
SCHEMBL28322767 0.87 TSHR (0.56) CYP1A2CYP2C19LMNACYP2C9TSHR
SCHEMBL12715082 0.87 LMNA (0.91) CYP1A2CYP2C19LMNACYP2C9YAP1
SCHEMBL11579676 0.87 LMNA (0.67) CYP1A2CYP2C19LMNACYP2C9YAP1
SCHEMBL4563521 0.86 LMNA (0.68) CYP1A2CYP2C19LMNACYP2C9YAP1
SCHEMBL3812938 0.86 LMNA (0.70) CYP1A2CYP2C19LMNACYP2C9YAP1
Etofenamate SCHEMBL25152 0.83 LMNA (1.00) CYP1A2CYP2C19LMNACYP2C9YAP1
SCHEMBL20820718 0.83 LMNA (0.64) CYP1A2CYP2C19LMNACYP2C9YAP1
Acetic Acid SCHEMBL28343495 0.83 LMNA (0.64) CYP1A2CYP2C19LMNACYP2C9YAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1421 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250332120-A1 COMPOSITION FOR EXTERNAL PREPARATION KAO CORPORATION (JP) 2025-10-30 US claimed
EP-4615506-A1 USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES Sahin, Fikret (TR) 2025-09-17 EP claimed
CN-117782740-B Sample treatment fluid for centrifugal microfluidic disc type biochemical analysis chip 阿里生物技术泰州有限公司 2025-03-25 CN claimed
WO-2024258363-A1 USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES SAHIN FIKRET (TR) 2024-12-19 WO claimed
CN-113679658-A Soluble microneedle patch for itching-relieving and anti-allergic treatment of skin and preparation method thereof 浙江瑞瞳生物科技有限公司 2021-11-23 CN claimed
CN-111246888-A Composition for ameliorating skin disorder 日本乐敦制药株式会社 2020-06-05 CN claimed
WO-2019078370-A1 COMPOSITION FOR AMELIORATING SKIN DISORDERS ロート製薬株式会社 2019-04-25 WO claimed
WO-2016109243-A1 ANALGESIC CLEANSING COMPOSITION THE DIAL CORPORATION (US) 2016-07-07 WO claimed
US-20160184203-A1 ANALGESIC CLEANSING COMPOSITION THE DIAL CORPORATION (US) 2016-06-30 US claimed
US-9364402-B1 Analgesic cleansing composition THE DIAL CORPORATION (US) 2016-06-14 US claimed
CN-1747731-A Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders ALTANA PHARMA AG (DE) 2006-03-15 CN claimed
EP-1599175-A2 IMIDAZOPYRIDINES CONTAINING COMBINATIONS AND THEIR USE IN TREATING GASTROINTESTINAL INFLAMMATORY DISORDERS ALTANA Pharma AG (DE) 2005-11-30 EP claimed
WO-2005074930-A1 PHARMACEUTICAL COMBINATIONS OF (S) -PANTOPRAZOLE WITH NSAID OR CORTICOSTEROIDS ALTANA PHARMA AG (DE) 2005-08-18 WO claimed
CN-1625411-A Combination of a NSAID and a PDE-4 inhibitor ALTANA PHARMA AG (DE) 2005-06-08 CN claimed
US-20040242597-A1 Combination NYCOMED GMBH (DE) 2004-12-02 US claimed
WO-2004071391-A2 IMIDAZOPYRIDINES CONTAINING COMBINATIONS AND THEIR USE IN TREATING GASTROINTESTINAL INFLAMMATORY DISORDERS ALTANA PHARMA AG (DE) 2004-08-26 WO claimed
EP-1429807-A2 COMBINATION OF A NSAID AND A PDE-4 INHIBITOR ALTANA Pharma AG (DE) 2004-06-23 EP claimed
EP-1336602-A1 Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases Scaramuzzino, Giovanni (IT) 2003-08-20 EP claimed
WO-2003024489-A2 COMBINATION OF A NSAID AND A PDE-4 INHIBITOR ALTANA PHARMA AG (DE) 2003-03-27 WO claimed
US-4594357-A Depot antiinflammatory agents TROPONWERKE GMBH & CO. (DE) 1986-06-10 US claimed